Across the UK, there are national screening programmes for breast, bowel and cervical cancer. Additionally, some nations are beginning targeted lung screening.
Find out about FIT, read the latest evidence and find resources to support informed participation.
Get resources to support uptake, including information on safety netting and barriers to participation.
Read information on the rollout of targeted screening and other ways to improve lung cancer outcomes.
At-a-glance information, including uptake and eligibility across the UK.
Screening at a glance(PDF, 107 KB)
Tips and information to help address breast, bowel and cervical screening inequalities.
Reducing inequalities in cancer screening(PDF, 306 KB)
Our Early Diagnosis Data Hub gathers information and statistics across a number of cancer early diagnosis and screening measures.
To improve screening programmes, it’s vital to standardise processes for how evidence and research is gathered.
Overdiagnosis is the diagnosis of a cancer that wouldn’t have gone on to cause harm in a person’s lifetime. In other words, if the person hadn’t been tested (whether that’s screening or some other type of test), the person might never have known they had cancer, and would not have died from the disease.
Overdiagnosis is one of the key things to consider when working out the balance of possible benefits and harms of cancer screening.
Read about the UK’s screening programmes, eligibility, benefits and risks.
Read our public cancer screening informationRead news, updates and opinion, posted weekly.
Stay up-to-date with the latest cancer research information.
